Terms: = Skin cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Treatment
179 results:
1. Review of the European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2022.
Morton CA; Szeimies RM; Braathen LR
Eur J Dermatol; 2023 Oct; 33(5):467-473. PubMed ID: 38297922
[TBL] [Abstract] [Full Text] [Related]
2. Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment.
Masel R; Roche ME; Martinez-Outschoorn U
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101514. PubMed ID: 38092473
[TBL] [Abstract] [Full Text] [Related]
3. Anti-melanoma and antioxidant properties of the methanol extract from the leaves of
Evariste Leonce AA; Devi P; Richard TS; Panda B; Devabattula G; Godugu C; Phelix Bruno T
J Complement Integr Med; 2024 Mar; 21(1):88-100. PubMed ID: 37916849
[TBL] [Abstract] [Full Text] [Related]
4. Tumor Profiles of Late Presentation Uveal Ring Melanoma With Novel Characteristics - A Case Series.
Lim JZ; Crawford AZ; McGhee CNJ
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):44. PubMed ID: 37889509
[TBL] [Abstract] [Full Text] [Related]
5. Tumor-infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer.
Jacover A; Zarbiv Y; Tal KH; Klein S; Breuer S; Durst R; Avni B; Grisariu S; Stepensky P; Lotem M; Maimon O; Yablonski-Peretz T
Cancer Rep (Hoboken); 2023 Dec; 6(12):e1894. PubMed ID: 37750497
[TBL] [Abstract] [Full Text] [Related]
6. Ezrin Inhibition Overcomes Acquired Resistance to Vemurafenib in BRAFV600E-Mutated Colon cancer and Melanoma Cells In Vitro.
Car I; Dittmann A; Vasieva O; Bočkor L; Grbčić P; Piteša N; Klobučar M; Kraljević Pavelić S; Sedić M
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629086
[TBL] [Abstract] [Full Text] [Related]
7. Identification of BRAF, CCND1, and myc mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
8. myc Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2.
Markovits E; Harush O; Baruch EN; Shulman ED; Debby A; Itzhaki O; Anafi L; Danilevsky A; Shomron N; Ben-Betzalel G; Asher N; Shapira-Frommer R; Schachter J; Barshack I; Geiger T; Elkon R; Besser MJ; Markel G
Cancer Immunol Res; 2023 Jul; 11(7):909-924. PubMed ID: 37074069
[TBL] [Abstract] [Full Text] [Related]
9. Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways.
Spain L; Coulton A; Lobon I; Rowan A; Schnidrig D; Shepherd STC; Shum B; Byrne F; Goicoechea M; Piperni E; Au L; Edmonds K; Carlyle E; Hunter N; Renn A; Messiou C; Hughes P; Nobbs J; Foijer F; van den Bos H; Wardenaar R; Spierings DCJ; Spencer C; Schmitt AM; Tippu Z; Lingard K; Grostate L; Peat K; Kelly K; Sarker S; Vaughan S; Mangwende M; Terry L; Kelly D; Biano J; Murra A; Korteweg J; Lewis C; O'Flaherty M; Cattin AL; Emmerich M; Gerard CL; Pallikonda HA; Lynch J; Mason R; Rogiers A; Xu H; Huebner A; McGranahan N; Al Bakir M; Murai J; Naceur-Lombardelli C; Borg E; Mitchison M; Moore DA; Falzon M; Proctor I; Stamp GWH; Nye EL; Young K; Furness AJS; Pickering L; Stewart R; Mahadeva U; Green A; Larkin J; Litchfield K; Swanton C; Jamal-Hanjani M; ; Turajlic S
Cancer Discov; 2023 Jun; 13(6):1364-1385. PubMed ID: 36977461
[TBL] [Abstract] [Full Text] [Related]
10. HDAC7/c-myc signaling pathway promotes the proliferation and metastasis of choroidal melanoma cells.
Zhang Y; Ding P; Wang Y; Shao C; Guo K; Yang H; Feng Y; Ning J; Pan M; Wang P; Yan X; Ma Z; Han J
Cell Death Dis; 2023 Jan; 14(1):38. PubMed ID: 36653340
[TBL] [Abstract] [Full Text] [Related]
11. The capillary lobule variant of radiation-associated angiosarcoma in the setting of breast cancer: A diagnostic pitfall.
Agrawal S; Fritchie KJ; Fernandez AP; Ko JS; Bergfeld W; Rubin BP; Billings SD
J Cutan Pathol; 2023 Feb; 50(2):140-146. PubMed ID: 36107728
[TBL] [Abstract] [Full Text] [Related]
12. α-Enolase inhibits apoptosis and promotes cell invasion and proliferation of skin cutaneous melanoma.
Zhang K; Tian R; Zhang W; Li Y; Zeng N; Liang Y; Tang S
Mol Biol Rep; 2022 Sep; 49(9):8241-8250. PubMed ID: 35925486
[TBL] [Abstract] [Full Text] [Related]
13. The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in Cutaneous T-Cell Lymphoma Can Be Reproduced by ΔNp73 Depletion.
Zhao L; Hsiao T; Stonesifer C; Daniels J; Garcia-Saleem TJ; Choi J; Geskin L; Rook AH; Wood GS
J Invest Dermatol; 2022 Dec; 142(12):3253-3261.e4. PubMed ID: 35787399
[TBL] [Abstract] [Full Text] [Related]
14. Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment.
Morimoto Y; Fushimi A; Yamashita N; Hagiwara M; Bhattacharya A; Cheng J; Frost TC; Ahmad R; Daimon T; Huang L; Hata T; Takahashi H; Yamamoto M; Suzuki Y; DeCaprio JA; Kufe D
Oncogene; 2022 Jul; 41(27):3511-3523. PubMed ID: 35688945
[TBL] [Abstract] [Full Text] [Related]
15. Alantolactone Inhibits Melanoma Cell Culture Viability and Migration and Promotes Apoptosis by Inhibiting Wnt/β-Catenin Signaling.
Zhang L; Chen J; Chen Y; Zou D; Pu Y; Wei M; Huang Y; Li Y; Huang Q; Chen J
Anticancer Agents Med Chem; 2023; 23(1):94-104. PubMed ID: 35598249
[TBL] [Abstract] [Full Text] [Related]
16. Atypical vascular lesions extending outside the radiation field: a diagnostic challenge.
Breneman A; Hooey L; Spicknall KE; Breneman DL
Dermatol Online J; 2021 Dec; 27(12):. PubMed ID: 35499441
[TBL] [Abstract] [Full Text] [Related]
17. Cutaneous Angiosarcomas: Molecular Pathogenesis Guides Novel Therapeutic Approaches.
Goerdt LV; Schneider SW; Booken N
J Dtsch Dermatol Ges; 2022 Apr; 20(4):429-443. PubMed ID: 35218306
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS).
Tong S; Cinelli MA; El-Sayed NS; Huang H; Patel A; Silverman RB; Yang S
Sci Rep; 2022 Feb; 12(1):1701. PubMed ID: 35105915
[TBL] [Abstract] [Full Text] [Related]
19. Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up-regulation and increased apoptosis resistance upon vemurafenib treatment.
Weitzenböck HP; Gschwendtner A; Wiesner C; Depke M; Schmidt F; Trautinger F; Hengstschläger M; Hundsberger H; Mikula M
Cancer Med; 2022 Feb; 11(4):956-967. PubMed ID: 34951143
[TBL] [Abstract] [Full Text] [Related]
20. Visualization of endogenous p27 and Ki67 reveals the importance of a c-myc-driven metabolic switch in promoting survival of quiescent cancer cells.
La T; Chen S; Guo T; Zhao XH; Teng L; Li D; Carnell M; Zhang YY; Feng YC; Cole N; Brown AC; Zhang D; Dong Q; Wang JY; Cao H; Liu T; Thorne RF; Shao FM; Zhang XD; Jin L
Theranostics; 2021; 11(19):9605-9622. PubMed ID: 34646389
[No Abstract] [Full Text] [Related]
[Next]
